Shaanxi Haoqijun Pharmaceutical

Shaanxi Haoqijun Pharmaceutical is a prominent Chinese pharmaceutical company focused on the research, development, and production of Traditional Chinese Medicines (TCM) for hematological and oncological conditions. Founded in 1996 by the renowned hematologist Hao Qijun, the company is a leader in the treatment of blood-related diseases such as aplastic anemia, thrombocytopenia, and leukopenia. Its flagship products, including Fufang Zaofan Wan and Sheng Xue Xiaoban Jiaonang, are widely recognized in China for their efficacy in stimulating bone marrow function and increasing blood cell counts. Headquartered in Xi'an, Shaanxi, the company operates GMP-certified manufacturing facilities and maintains a strong presence in both the clinical and commercial pharmaceutical sectors. The company also operates an affiliated hospital specializing in blood disease research and treatment.